A detailed history of Annapolis Financial Services, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Annapolis Financial Services, LLC holds 22 shares of BIIB stock, worth $3,823. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Holding current value
$3,823
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$189.07 - $236.8 $4,159 - $5,209
22 New
22 $4,000
Q3 2022

Oct 21, 2022

SELL
$194.69 - $268.46 $19,469 - $26,845
-100 Reduced 98.04%
2 $1,000
Q4 2020

Feb 11, 2021

BUY
$236.26 - $355.63 $24,098 - $36,274
102 New
102 $25,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Annapolis Financial Services, LLC Portfolio

Follow Annapolis Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annapolis Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annapolis Financial Services, LLC with notifications on news.